Statistics
Publications
1
Citations
273
H-Index
1
Active since
2006
Affiliations
Harvard University Press(Current)
Ken Wyman is an author at Harvard University Press specializing in pdgfr inhibitors, oncology, and tumor progression.
Publications per year
2006–2006
1
1
Multicenter Phase II trial of high‐dose imatinib mesylate in metastatic melanoma
Ken Wyman, Michael B. Atkins, Víctor M. Prieto et al. · Cancer · 2006 · 273 citations
Medicine, Oncology, Pharmacology +10
1–1 of 1